Core Insights - Aurora Spine Corporation reported its financial results for the third quarter of 2025, highlighting a transition phase with the launch of two new product platforms, DEXA-L and Hydra ARO, aimed at enhancing its proprietary product offerings [1][3]. Financial and Business Highlights - Total revenues for Q3 2025 were $4.43 million, a decrease of 7.1% from $4.77 million in Q3 2024, primarily due to a transition from third-party lumbar screws to the Osteo Onyx lumbar product, with lumbar screw sales down 30% from Q1 2025 [5]. - The company achieved sustained revenue performance, marking the fifth consecutive quarter with sales exceeding $4.4 million, and a cumulative sales increase of $484,698 over the comparable period last year [6]. - EBITDAC for Q3 2025 was $165,600, an increase from $141,745 in the previous quarter, indicating positive operational performance [6]. - Gross margin improved slightly to 60.9% in Q3 2025 from 60.5% in Q3 2024, attributed to increased direct sales reducing distributor commissions [7]. Management Commentary - The CEO expressed confidence in the company's proprietary product platforms, emphasizing their potential to revolutionize spinal pain treatment through minimally invasive procedures and the importance of educating medical professionals about these products [3]. - The CFO noted the company's efficient operations, focusing on cash collections and expense management while remaining capitalized for growth opportunities [4]. Operating Expenses and Net Loss - Total operating expenses for Q3 2025 were $2.81 million, consistent with the same period in 2024, despite higher marketing expenses being offset by reductions in general and administrative costs [8]. - The net loss for Q3 2025 was $(0.142) million, compared to a net income of $0.070 million in Q3 2024, with basic and diluted net loss per share remaining at $(0.00) [10]. Selected Financial Position Information - As of September 30, 2025, the company had total assets of $11.69 million, with cash at $665,757 and current liabilities at $4.58 million [12].